Handelsavisen
prelaunch
Companies Healthcare 3628.T
36
3628.T Tokyo Stock Exchange Advanced Medical Equipment & Technology

Data Horizon Co Ltd

¥515,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
6,5B JPY
P/E
EV / Rev
2,2x
Div yield
0,00 %
Op margin
-0,4 %
ROE
-2,3 %
Net margin
-4,9 %
Debt / equity
1,21
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Data Horizon Co Ltd designs, develops, and sells medical equipment and related software solutions for diagnostic and therapeutic applications in the healthcare industry.

Business. Data Horizon Co Ltd (3628.T) is a Japanese company engaged in the healthcare equipment industry, specifically within the advanced medical equipment and technology sector. The firm operates primarily through a product-sale revenue model, focusing on the development and distribution of medical devices. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-2,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 3628.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 3628.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Data Horizon Co Ltd (3628.T) is a Japanese company engaged in the healthcare equipment industry, specifically within the advanced medical equipment and technology sector. The firm operates primarily through a product-sale revenue model, focusing on the development and distribution of medical devices. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Data Horizon Co Ltd has a market price of ¥639 per share, translating to a market capitalization of ¥8.11 billion. The company's price-to-book ratio is 2.32, and its price-to-tangible-book ratio is also 2.32, indicating that the market is valuing the company at a premium to its book value. The enterprise value to EBITDA ratio is negative at -1788.91, reflecting the company's current operating losses. The enterprise value to revenue ratio is 7.0, suggesting that the company is trading at a multiple of 7 times its revenue.

    The company's profitability metrics are concerning. The return on equity is -2.29%, and the return on assets is -0.91%, both indicating a negative return on invested capital. The gross profit margin is 35.15% (¥573.04 million / ¥1.63 billion), which is relatively high for a medical equipment company, but the operating loss of ¥6.38 million and net loss of ¥80.01 million suggest significant cost pressures or operational inefficiencies.

    Data Horizon Co Ltd's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company does not provide geographic revenue breakdowns, but its operations are primarily based in Japan, with no material international revenue disclosed. This lack of geographic diversification could expose the company to regional economic or regulatory risks.

    The company's growth trajectory is uncertain. Revenue for the latest period is ¥1.63 billion, but there is no disclosed prior period data to assess year-over-year growth. The company is currently operating at a loss, and without a clear path to profitability or significant revenue growth, its long-term growth prospects are unclear.

    The company's liquidity position is medium risk, with a current ratio of 0.93, indicating that it has slightly more current liabilities than current assets. The debt-to-equity ratio is 1.21, suggesting that the company is leveraged, with ¥4.24 billion in long-term debt compared to ¥3.496 billion in equity. The risk assessment indicates that the company has negative net cash after subtracting total debt, which could limit its financial flexibility. The dilution risk is currently low, with no significant dilution expected in the near term.

    There are no recent events or filings disclosed in the provided data that would indicate significant changes in the company's operations or financial position. The company's financial statements do not mention any recent strategic initiatives, product launches, or regulatory changes that could impact its future performance.

    Key takeaways
    • Data Horizon Co Ltd is currently operating at a loss, with a net loss of ¥80.01 million and an operating loss of ¥6.38 million.
    • The company's market valuation is at a premium to book value, with a price-to-book ratio of 2.32.
    • The company's liquidity position is weak, with a current ratio of 0.93 and a debt-to-equity ratio of 1.21.
    • The company's profitability metrics are negative, with a return on equity of -2.29% and a return on assets of -0.91%.
    • The company's revenue is concentrated in a single business segment, with no material international revenue disclosed.
    • The company's growth trajectory is uncertain, with no disclosed prior period data to assess year-over-year growth.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 2

    Revenue grew at a 3.7% CAGR over four years, showing modest top-line expansion despite recent volatility.

    Dilution risk is assessed as low, providing some stability for existing shareholders regarding equity structure.

    BEAR CASE · 3

    Long-term debt surged to 4.81 billion JPY, more than doubling from the prior year and increasing financial leverage significantly.

    The company faces high credit risk, raising concerns about its ability to meet financial obligations and service debt.

    Debt-to-equity ratio of 1.21 places the company in the bottom quartile of its cohort, indicating excessive leverage.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-05
    Q4 2025 · Quarter highlights

    Revenue ¥1.42B, +28,7% YoY; Operating income +157,4% YoY.

    Revenue¥1.42B+28,7 % YoY
    Operating income¥151.5M+157,4 % YoY
    Net income¥149.5M+159,1 % YoY
    Free cash flow
    EPS
    Operating cash flow
    Financials
    Income statement
    Revenue¥1.42B
    Gross profit¥599.7M
    Operating income¥151.5M
    Net income¥149.5M
    Margins
    Gross margin42.3%
    Operating margin10.7%
    Net margin10.5%
    FCF margin
    Balance sheet
    Total assets¥6.05B
    Total liabilities¥5.75B
    Total equity¥301.3M
    Cash & equivalents¥1.03B
    Long-term debt¥4.93B
    P&L flow · revenue → net income
    Revenue ¥1.42BOperating costs ¥1.27BTax ¥2.0MNet income ¥149.5M
    Highlights
    • Revenue ¥1.42B, +28,7% YoY
    • Operating income +157,4% YoY
    • Net income +159,1% YoY
    • Net margin 10.5%

    Valuation TTM

    Market price
    ¥515,00
    Market cap
    ¥8.11B
    Enterprise value
    ¥11.42B
    P/E
    Non-GAAP P/E
    EV / Revenue
    2.2x
    EV / Op income
    EV / OCF
    P / B
    2.3x
    P / Tangible book
    2.3x
    Tangible book
    ¥3.50B
    Net cash
    -¥3.31B
    Current ratio
    0.9
    Debt / equity
    1.2
    ROA
    -0.9%
    ROE
    -2.3%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-0,4 %Above median
    Net Margin-4,9 %Above median
    ROE-2,3 %Above median
    D/E1,21Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • Data Horizon Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    3628.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-02-05 12:00 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 1.42B · Net JPY 149.5M
    2025-11-10 12:00 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 1.10B · Net JPY -3.5M
    2025-08-07 12:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 991.2M · Net JPY -55.7M
    2025-05-09 12:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 1.67B · Net JPY -2.39B
    2025-02-07 12:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 1.10B · Net JPY -252.8M
    2024-11-06 12:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 1.08B · Net JPY -319.4M
    2024-08-08 11:30 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 1.00B · Net JPY -307.1M
    2024-08-08 11:30 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 5.01B · Net JPY -807.2M
    2024-05-08 11:30 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 1.63B · Net JPY -80.0M
    2023-08-09 11:30 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 4.41B · Net JPY -664.9M
    2022-08-10 12:00 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 2.99B · Net JPY -410.8M
    2021-08-11 11:30 UTCEARNINGSAnnual results — FY 2021 Revenue JPY 3.33B · Net JPY 283.9M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage